Tsamesidis, I.; Drillis, G.; Varlamis, S.; Smaragdaki, N.; Klonizakis, P.; Dimou, M.; Liapis, K.; Vrahiolias, G.; Andreadou, E.; Mitka, S.;
et al. Novel Approaches to the Management of Myelodysplastic Syndromes: The Roles of Artificial Intelligence and Oxidative Stress Biomarkers. Hematol. Rep. 2026, 18, 33.
https://doi.org/10.3390/hematolrep18030033
AMA Style
Tsamesidis I, Drillis G, Varlamis S, Smaragdaki N, Klonizakis P, Dimou M, Liapis K, Vrahiolias G, Andreadou E, Mitka S,
et al. Novel Approaches to the Management of Myelodysplastic Syndromes: The Roles of Artificial Intelligence and Oxidative Stress Biomarkers. Hematology Reports. 2026; 18(3):33.
https://doi.org/10.3390/hematolrep18030033
Chicago/Turabian Style
Tsamesidis, Ioannis, Georgios Drillis, Sotirios Varlamis, Niki Smaragdaki, Philippos Klonizakis, Maria Dimou, Konstantinos Liapis, Georgios Vrahiolias, Eleni Andreadou, Stella Mitka,
and et al. 2026. "Novel Approaches to the Management of Myelodysplastic Syndromes: The Roles of Artificial Intelligence and Oxidative Stress Biomarkers" Hematology Reports 18, no. 3: 33.
https://doi.org/10.3390/hematolrep18030033
APA Style
Tsamesidis, I., Drillis, G., Varlamis, S., Smaragdaki, N., Klonizakis, P., Dimou, M., Liapis, K., Vrahiolias, G., Andreadou, E., Mitka, S., Chatzidimitriou, M., Kotsianidis, I., Skepastianos, P., Kriebardis, A. G., & Pessach, I.
(2026). Novel Approaches to the Management of Myelodysplastic Syndromes: The Roles of Artificial Intelligence and Oxidative Stress Biomarkers. Hematology Reports, 18(3), 33.
https://doi.org/10.3390/hematolrep18030033
